STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

SUSAN G KOMEN BREAST CANCER FOUNDATION: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
SUSAN G KOMEN BREAST CANCER FOUNDATION (EIN 75-1835298)
Tax period
2019-04-01 to 2020-03-31
Filed
2021-01-04
IRS object ID
202140089349300504
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-01-04T14:50:47-06:00ReturnTs
Tax Period End2020-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line11901 6TH AVE NAddressLine1Txt
CityBIRMINGHAMCityNm
State AbbreviationALStateAbbreviationCd
ZIP35203ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN751835298EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Susan G Komen Breast Cancer Fdn IncBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% RIA WILLIAMSInCareOfNm
Business Name ControlSUSABusinessNameControlTxt
Phone9728551600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line113770 Noel Road Suite 801889AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP75380ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonPAULA SUE SCHNEIDERPersonNm
Person TitlePresident and CEOPersonTitleTxt
Phone9728551600PhoneNum
Signature2020-12-23SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonKATHY PITTSPreparerPersonNm
PTINP00292940PTIN
Phone2052541608PhoneNum
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Address ChangeYes (X)AddressChangeInd

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1SUSAN G KOMENBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerPaula Sue SchneiderPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line113770 Noel Road Suite 801889AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP75380ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$103,537,546GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Group Exemption7164GroupExemptionNum
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.komen.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1982FormationYr
Legal Domicile StateTXLegalDomicileStateCd
Activity Or MissionSUSAN G KOMENFIGHTS BREAST CANCER ON ALL FRONTS BY DRIVING RESEARCH, PUBLIC POLICY, EDUCATION & SUPPORT SERVICES FOR PEOPLE FACING BREAST CANCER TODAY.ActivityOrMissionDesc
Voting Members Governing Body11VotingMembersGoverningBodyCnt
Voting Members Independent11VotingMembersIndependentCnt
Total Employee263TotalEmployeeCnt
Total Volunteers1950TotalVolunteersCnt
Total Gross UBI$24,426TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm-$61,611NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$63,291,987PYContributionsGrantsAmt
CY Contributions Grants$59,972,314CYContributionsGrantsAmt
PY Program Service Revenue$12,975,072PYProgramServiceRevenueAmt
CY Program Service Revenue$11,229,901CYProgramServiceRevenueAmt
PY Investment Income$15,415,716PYInvestmentIncomeAmt
CY Investment Income$6,459,076CYInvestmentIncomeAmt
PY Other Revenue-$1,624,976PYOtherRevenueAmt
CY Other Revenue-$2,874,522CYOtherRevenueAmt
PY Total Revenue$90,057,799PYTotalRevenueAmt
CY Total Revenue$74,786,769CYTotalRevenueAmt
PY Grants And Similar Paid$29,481,585PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$1,959,840CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$22,862,266PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$24,559,389CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$2,527,973PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$1,917,235CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$17,178,126CYTotalFundraisingExpenseAmt
PY Other Expenses$37,154,373PYOtherExpensesAmt
CY Other Expenses$40,447,365CYOtherExpensesAmt
PY Total Expenses$92,026,197PYTotalExpensesAmt
CY Total Expenses$68,883,829CYTotalExpensesAmt
PY Revenues Less Expenses-$1,968,398PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$5,902,940CYRevenuesLessExpensesAmt
Total Assets BOY$192,149,996TotalAssetsBOYAmt
Total Assets EOY$151,061,886TotalAssetsEOYAmt
Total Liabilities BOY$75,529,111TotalLiabilitiesBOYAmt
Total Liabilities EOY$47,670,630TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$116,620,885NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$103,391,256NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSUSAN G. KOMEN IS FIGHTING BREAST CANCER ON ALL FRONTS BY DRIVING RESEARCH, PUBLIC POLICIES, EDUCATION, AND CRITICAL SERVICES TO PEOPLE FACING BREAST CANCER TODAY.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Activity32ActivityCd
Expense$32,476,282ExpenseAmt
Grant$495,346GrantAmt
Revenue$0RevenueAmt
DescPROVISION OF BREAST HEALTH/CANCER EDUCATION RESOURCES & PATIENT SUPPORT PROGRAMS WERE MADE POSSIBLE DIRECTLY BY KOMEN AND THROUGH GRANTS TO OTHER NONPROFIT ORGANIZATIONS TO INCREASE THE PUBLIC'S KNOWLEDGE OF BREAST CANCER, ITS RISK FACTORS, THE IMPORTANCE OF EARLY DETECTION & SCREENING, KNOWING WHAT IS NORMAL FOR YOU, LIFESTYLE CHOICES, DIAGNOSIS AND TREATMENT, METASTATIC BREAST CANCER, CLINICAL TRIALS, SOCIAL SUPPORT, COMMUNICATION, COMPLEMENTARY AND INTEGRATIVE THERAPIES, AND COMMUNITY RESOURCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Activity32ActivityCd
Expense$5,473,057ExpenseAmt
Grant$1,365,119GrantAmt
Revenue$11,260,930RevenueAmt
DescGRANTS TO RESEARCH INSTITUTIONS AND OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS INCLUDING THOSE FOCUSED ON THE BIOLOGY OF BREAST CANCER; NEW STRATEGIES TO TREAT, DETECT, AND PREDICT RISK OF BREAST CANCER, AND UNDERSTANDING AND ADDRESSING DISPARITIES IN OUTCOMES. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Activity32ActivityCd
Expense$2,399,558ExpenseAmt
Grant$99,375GrantAmt
Revenue$538,636RevenueAmt
DescPROVISION OF BREAST CANCER SCREENING, DIAGNOSIS, AND TREATMENT PROGRAMS THROUGH GRANTS TO OTHER NON-PROFIT ORGANIZATIONS, THIRD-PARTY CONTRACTS AND DIRECTLY BY KOMEN, WITH A SPECIAL EMPHASIS ON PATIENT NAVIGATION, ESPECIALLY IN COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$40,348,897TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document83IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee263EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members11GoverningBodyVotingMembersCnt
Independent Voting Member11IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsYes (true)ChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonRIA WILLIAMSPersonNm
Phone9728551600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line113770 NOEL ROAD SUITE 801889AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP75380ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (34 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
Paula Schneider
President and CEO55.00.0Yes (X)$631,413$0$23,166
Christina Alford
SVP, Development55.00.0$326,215$0$19,538Yes (X)
Dana Brown
CHIEF OPERATING OFFICER55.00.0Yes (X)$330,938$0$3,303
Victoria Wolodzko
VP RESEARCH AND COM. HEALTH PR55.00.0$260,252$0$14,182Yes (X)
Catherine Olivieri EN
VP, HR and Corporate Secretary55.00.0Yes (X)$237,337$0$27,885
Ria Williams
Chief Financial Officer55.00.0Yes (X)$229,458$0$25,918
Linda Fisk
SVP, Marketing (END 10/19)55.00.0$231,553$0$14,829Yes (X)
Lori Maris
SVP, Affiliate Network55.00.0$196,203$0$14,737Yes (X)
Kimberly Sabelko
Sr. Dir., Scientific Strategy55.00.0$166,787$0$21,106Yes (X)
Vanessa Hewitt
Sr. Dir., Internal Audit55.00.0$168,574$0$18,979Yes (X)
Sue Aldana
VP, Collaborative Revenue55.00.0$169,301$0$12,537Yes (X)
Subhendu Rath END 71
Sr. Dir, IT Enterprise Systems55.00.0$169,192$0$10,402Yes (X)
Eric Montgomery
VP, I.T. (END 4/19)55.00.0$164,984$0$13,862Yes (X)
Kimberly Johnson
Sr Dir Afri-Am Hlth Equity55.00.0$168,628$0$2,110Yes (X)
Eunice Nakamura BEG 6
Gen Counsel and Corp Secretary55.00.0Yes (X)$112,770$0$2,988
Connie O'Neill
BOARD MEMBER (END 6/19)1.00.0$0$0$0Yes (X)
Linda Custard
BOARD MEMBER (END 6/19)1.00.0$0$0$0Yes (X)
Meghan Shannon Brendt
BOARD MEMBER (END 6/19)1.00.0$0$0$0Yes (X)
Trish Wheaton
BOARD MEMBER (END 6/19)1.00.0$0$0$0Yes (X)
Angela Zepeda
BOARD MEMBER (END 6/19)1.00.0$0$0$0Yes (X)
Kim Bohr
BOARD MEMBER (END 3/20)1.00.0$0$0$0Yes (X)
Andrew Robinson
BOARD MEMBER (END 3/20)1.00.0$0$0$0Yes (X)
Kaye Ceille
BOARD Member1.00.0$0$0$0Yes (X)
Doug Knutson MD
BOARD Member1.00.0$0$0$0Yes (X)
Kristin Nimsger
Board Member1.00.0$0$0$0Yes (X)
Stephanie Stahl
BOARD MEMBER1.00.0$0$0$0Yes (X)
Peter D Brundage
Chair of the Board1.00.0Yes (X)$0$0$0Yes (X)
John O'Neil
Board Member (BEG 6/19)1.00.0$0$0$0Yes (X)
Christina Minnis
Board Member (BEG 6/19)1.00.0$0$0$0Yes (X)
Susannah Gray
Board Member (BEG 6/19)1.00.0$0$0$0Yes (X)
Jerri Johnson
Board Member (BEG 6/19)1.00.0$0$0$0Yes (X)
Kwanza Jones
Board Member (BEG 6/19)1.00.0$0$0$0Yes (X)
Eugene Kim
Board Member (BEG 6/19)1.00.0$0$0$0Yes (X)
Michael B GreenwaldE
BOARD MEMBER & TREASURER1.00.0Yes (X)$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,563,605TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$225,542TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K54IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNmCountryContractorAddress/ForeignAddress/CountryCdForeign PostalContractorAddress/ForeignAddress/ForeignPostalCd
Event 360 Inc
205 N MICHIGAN AVECHICAGOIL60601EVENT MANAGEMENT$5,152,908
THE ADVERTISING COUNCIL inc
815 SECOND AVENUE 9TH FLOORNEW YORKNY10017MARKETING$1,062,811
RKD Group LLC
3400 Waterview Parkway Suite 250RICHARDSONTX75080CONSULTING$732,000
Laurel Strategies Inc
4A Oxford StreetCHEVY CHASEMD20815CONSULTING$480,000
Stephen Thomas Ltd
DIRECT MKTNG SRVCS$458,856184 FRONT STREET EAST SUITE 501TORONTOONTARIOCAM5A 4N3
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K18CntrctRcvdGreaterThan100KCnt
Federated Campaigns$231,422FederatedCampaignsAmt
Fundraising$15,804,036FundraisingAmt
All Other Contributions$43,936,856AllOtherContributionsAmt
Noncash Contributions$151,667NoncashContributionsAmt
Total Contributions$59,972,314TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescAFFILIATE PROGRAM FUNDINGDesc
Business900099BusinessCd
Total Revenue Column$11,229,901TotalRevenueColumnAmt
Related Or Exempt Func Income$11,229,901RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$11,229,901TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,926,211TotalRevenueColumnAmt
Exclusion$4,926,211ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,627TotalRevenueColumnAmt
Exclusion$2,627ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$26,160,315SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$24,627,450SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$1,532,865SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,532,865TotalRevenueColumnAmt
Exclusion$1,532,865ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$377,028FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$15,804,036ContriRptFundraisingEventAmt
Fundraising Direct Expenses$3,910,284FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$3,533,256TotalRevenueColumnAmt
Exclusion-$3,533,256ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$183,725GrossSalesOfInventoryAmt
Cost Of Goods Sold$213,043CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column-$29,318TotalRevenueColumnAmt
Related Or Exempt Func Income-$29,318RelatedOrExemptFuncIncomeAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
SHARED SERVICES INCOME900099$598,983$598,983$0$0
OTHER INCOME900099$86,442$0$24,426$62,016
FieldValueIRS element (for citing)
Other Revenue Total$685,425OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$74,786,769TotalRevenueColumnAmt
Related Or Exempt Func Income$11,799,566RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$24,426UnrelatedBusinessRevenueAmt
Exclusion$2,990,463ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$1,959,840TotalAmt
Program Services$1,959,840ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,939,628TotalAmt
Program Services$1,910,758ProgramServicesAmt
Management And General$382,152ManagementAndGeneralAmt
Fundraising$646,718FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$18,072,553TotalAmt
Program Services$8,545,640ProgramServicesAmt
Management And General$5,837,188ManagementAndGeneralAmt
Fundraising$3,689,725FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$603,167TotalAmt
Program Services$285,307ProgramServicesAmt
Management And General$208,225ManagementAndGeneralAmt
Fundraising$109,635FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,711,195TotalAmt
Program Services$757,271ProgramServicesAmt
Management And General$623,993ManagementAndGeneralAmt
Fundraising$329,931FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,232,846TotalAmt
Program Services$593,726ProgramServicesAmt
Management And General$378,928ManagementAndGeneralAmt
Fundraising$260,192FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$118,116TotalAmt
Program Services$53,915ProgramServicesAmt
Management And General$21,520ManagementAndGeneralAmt
Fundraising$42,681FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$341,547TotalAmt
Management And General$341,547ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$241,823TotalAmt
Program Services$241,823ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$1,917,235TotalAmt
Fundraising$1,917,235FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$216,323TotalAmt
Management And General$216,323ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$3,896,089TotalAmt
Program Services$2,623,917ProgramServicesAmt
Management And General$80,107ManagementAndGeneralAmt
Fundraising$1,192,065FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$13,420,103TotalAmt
Program Services$8,005,023ProgramServicesAmt
Management And General$130,398ManagementAndGeneralAmt
Fundraising$5,284,682FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,675,406TotalAmt
Program Services$1,089,014ProgramServicesAmt
Management And General$217,803ManagementAndGeneralAmt
Fundraising$368,589FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,076,477TotalAmt
Program Services$488,238ProgramServicesAmt
Management And General$456,875ManagementAndGeneralAmt
Fundraising$131,364FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,609,758TotalAmt
Program Services$1,207,377ProgramServicesAmt
Management And General$160,498ManagementAndGeneralAmt
Fundraising$241,883FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$625,982TotalAmt
Program Services$516,047ProgramServicesAmt
Management And General$31,127ManagementAndGeneralAmt
Fundraising$78,808FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$371,810TotalAmt
Program Services$124,950ProgramServicesAmt
Management And General$156,036ManagementAndGeneralAmt
Fundraising$90,824FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$316,930TotalAmt
Program Services$555ProgramServicesAmt
Management And General$316,076ManagementAndGeneralAmt
Fundraising$299FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
CONSULTING & PROF.SVCS.$9,708,673$8,064,451$557,876$1,086,346
EVENT PRODUCTION$2,703,616$2,177,755$1,644$524,217
EQUIP. RENTAL & MAINT$1,970,120$669,672$641,340$659,108
Bank Fees$886,930$523,629$105,291$258,010

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$1,267,662TotalAmt
Program Services$509,989ProgramServicesAmt
Management And General$491,859ManagementAndGeneralAmt
Fundraising$265,814FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$68,883,829TotalAmt
Program Services$40,348,897ProgramServicesAmt
Management And General$11,356,806ManagementAndGeneralAmt
Fundraising$17,178,126FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$39,349,373TotalAmt
Program Services$22,359,038ProgramServicesAmt
Management And General$28,566ManagementAndGeneralAmt
Fundraising$16,961,769FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$17,950,693BOYAmt
EOY$16,576,575EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$26,578,028BOYAmt
EOY$25,407,636EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$217,555BOYAmt
EOY$110,871EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,410,475BOYAmt
EOY$1,632,025EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$9,670,331LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$8,865,595LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$932,890BOYAmt
EOY$804,736EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$77,611,324BOYAmt
EOY$54,648,890EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$67,428,258BOYAmt
EOY$51,881,153EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$20,773BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$192,149,996BOYAmt
EOY$151,061,886EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$8,480,242BOYAmt
EOY$7,278,558EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$66,857,399BOYAmt
EOY$40,205,041EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$191,470BOYAmt
EOY$187,031EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$75,529,111BOYAmt
EOY$47,670,630EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$67,602,118BOYAmt
EOY$47,196,408EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$49,018,767BOYAmt
EOY$56,194,848EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$116,620,885BOYAmt
EOY$103,391,256EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$192,149,996BOYAmt
EOY$151,061,886EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$5,902,940ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$19,979,434NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$47,998DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Other Changes In Net Assets$798,867OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$105,234,559CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$55,634,984CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$51,441,732CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$63,291,987CurrentTaxYearMinus1YearAmt
Current Tax Year$59,972,314CurrentTaxYearAmt
Total$335,575,576TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$105,234,559CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$55,634,984CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$51,441,732CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$63,291,987CurrentTaxYearMinus1YearAmt
Current Tax Year$59,972,314CurrentTaxYearAmt
Total$335,575,576TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$43,034,806SubstantialContributorsTotAmt
Public Support Total170$292,540,770PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,523,145CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$2,265,964CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,667,273CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$5,221,701CurrentTaxYearMinus1YearAmt
Current Tax Year$4,928,838CurrentTaxYearAmt
Total$20,606,921TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$336,857CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$51,821CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$124,523CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$34,200CurrentTaxYearMinus1YearAmt
Current Tax Year$86,442CurrentTaxYearAmt
Total$633,843TotalAmt
FieldValueIRS element (for citing)
Total Support$356,816,340TotalSupportAmt
Gross Receipts Rltd Activities$80,221,196GrossReceiptsRltdActivitiesAmt
Public Support CY1700.81986PublicSupportCY170Pct
Public Support PY1700.83236PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Organization Belongs Afflt GrpYes (X)OrganizationBelongsAffltGrpInd

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$28,198FilingOrganizationsTotalAmt
Affiliated Group Total$86,368AffiliatedGroupTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$213,625FilingOrganizationsTotalAmt
Affiliated Group Total$257,094AffiliatedGroupTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$241,823FilingOrganizationsTotalAmt
Affiliated Group Total$343,462AffiliatedGroupTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$57,285,200FilingOrganizationsTotalAmt
Affiliated Group Total$113,727,651AffiliatedGroupTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$57,527,023FilingOrganizationsTotalAmt
Affiliated Group Total$114,071,113AffiliatedGroupTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt
Affiliated Group Total$1,000,000AffiliatedGroupTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt
Affiliated Group Total$250,000AffiliatedGroupTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$274,215CurrentYearMinus3Amt
Current Year Minus2$253,525CurrentYearMinus2Amt
Current Year Minus1$279,269CurrentYearMinus1Amt
Current Year$343,462CurrentYearAmt
Total$1,150,471TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$19,341CurrentYearMinus3Amt
Current Year Minus2$19,478CurrentYearMinus2Amt
Current Year Minus1$64,115CurrentYearMinus1Amt
Current Year$86,368CurrentYearAmt
Total$189,302TotalAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceLOBBYING EXPENSESFormAndLineReferenceDesc
ExplanationSCHEDULE C, PART II-A PUBLIC POLICY AND ADVOCACY INITIATIVES HAVE THE POTENTIAL TO IMPACT ALL PEOPLE TOUCHED BY BREAST CANCER. RECOGNIZING THE IMPORTANCE OF THIS WORK TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED ADVOCACY/LOBBYING ACTIVITIES TO ACHIEVE LEGISLATIVE AND REGULATORY SOLUTIONS DESIGNED TO SUPPORT KEY PATIENT PROTECTIONS, EXPAND ACCESS TO HIGH-QUALITY CARE, AND FUND CRITICAL BREAST CANCER RESEARCH.ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,333,603BeginningYearBalanceAmt
Investment Earnings Or Losses$9,803InvestmentEarningsOrLossesAmt
Other Expenditures$5,844OtherExpendituresAmt
End Year Balance$1,337,562EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,362,090BeginningYearBalanceAmt
Contributions$0ContributionsAmt
Investment Earnings Or Losses-$4,016InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$24,267OtherExpendituresAmt
Administrative Expenses$204AdministrativeExpensesAmt
End Year Balance$1,333,603EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,377,855BeginningYearBalanceAmt
Contributions$0ContributionsAmt
Investment Earnings Or Losses$10,034InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$25,799OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$1,362,090EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,376,069BeginningYearBalanceAmt
Investment Earnings Or Losses$1,786InvestmentEarningsOrLossesAmt
Other Expenditures$0OtherExpendituresAmt
End Year Balance$1,377,855EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,346,721BeginningYearBalanceAmt
Investment Earnings Or Losses$29,808InvestmentEarningsOrLossesAmt
Other Expenditures$460OtherExpendituresAmt
End Year Balance$1,376,069EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.75000BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.24000PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.01000TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$610,067OtherCostOrOtherBasisAmt
Depreciation$361,521DepreciationAmt
Book Value$248,546BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$2,561,000OtherCostOrOtherBasisAmt
Depreciation$2,376,758DepreciationAmt
Book Value$184,242BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$6,499,264OtherCostOrOtherBasisAmt
Depreciation$6,127,316DepreciationAmt
Book Value$371,948BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$804,736TotalBookValueLandBuildingsAmt
Financial DerivativesFinancialDerivativesGrp
Closely Held Equity InterestsCloselyHeldEquityInterestsGrp

Other Securities OtherSecuritiesGrp (2 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
DEFENSIVE EQUITY FUND$15,404,153F
PRIVATE EQUITY FUND$36,477,000F
FieldValueIRS element (for citing)
Total Book Value Securities$51,881,153TotalBookValueSecuritiesAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Intended use of endowment fundsSCHEDULE D, PART V, LINE 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS, THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS, AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES.
FIN 48 (ASC 740) FINANCIAL STATEMENT DISCLOSURESCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2020.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (21 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Central America and the Caribbean01GrantmakingEducation$4,000
East Asia and the Pacific04GrantmakingResearch$497,306
Europe (Including Iceland and Greenland)09GrantmakingResearch$574,184
Europe (Including Iceland and Greenland)01Program ServicesAffiliate Programs$44,000
Europe (Including Iceland and Greenland)01Program ServicesMembership$43,114
Europe (Including Iceland and Greenland)01GrantmakingEducation$40,000
Europe (Including Iceland and Greenland)02Program ServicesTransportation Service$32,267
Europe (Including Iceland and Greenland)02Program ServicesConference Support$23,687
Europe (Including Iceland and Greenland)01Program ServicesSystm&Softwr Maint&Srv$16,189
Europe (Including Iceland and Greenland)01Program ServicesLegal Services$3,331
Middle East and North Africa01Program ServicesHonorarium$1,850
North America01FundraisingDirect Mail Processing$1,173,024
North America04GrantmakingResearch$412,069
North America01Program ServicesVideo Services$76,196
North America01Program ServicesMembership$30,000
North America03Program ServicesSystm&Sftwr Maint&Srv$23,545
North America01GrantmakingEdu, Screening, Trtmnt$15,000
North America01Program ServicesAffiliate Support$240
Sub-Saharan Africa01GrantmakingEducation$15,000
Sub-Saharan Africa02Program ServicesConsulting Services$5,000
Sub-Saharan Africa01Program ServicesProfessional Services$2,577
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees35SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee5ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee40TotalEmployeeCnt
Subtotal Spent$3,009,762SubtotalSpentAmt
Continuation Spent$22,817ContinuationSpentAmt
Total Spent$3,032,579TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (19 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
North AmericaResearch$15,000WIRE TRANSFE
Europe (Including Iceland and Greenland)RESEARCH$30,000WIRE TRANSFE
North AmericaResearch$214,375WIRE TRANSFE
Europe (including Iceland and Greenland)Education$77,974WIRE TRANSFE
East Asia and the PacificResearch$239,672WIRE TRANSFE
East Asia and the PacificResearch$292,715WIRE TRANSFE
Europe (Including Iceland and Greenland)Research$94,188wire transfe
Europe (including Iceland and Greenland)Education$40,000WIRE TRANSFE
Europe (including Iceland and Greenland)Research$105,390WIRE TRANSFE
North AmericaResearch$29,998WIRE TRANSFE
Europe (Including Iceland and Greenland)Research$24,000WIRE TRANSFE
East Asia and the PacificResearch$36,000WIRE TRANSFE
North AmericaResearch$34,948WIRE TRANSFE
Europe (including Iceland and Greenland)Research$73,950WIRE TRANSFE
Sub-Saharan AfricaEducation$15,000WIRE TRANSFE
Europe (Including Iceland and Greenland)$15,000WIRE TRANSFE
Europe (Including Iceland and Greenland)Research$149,105WIRE TRANSFE
East Asia and the PacificResearch$78,710WIRE TRANSFE
North AmericaResearch$132,748WIRE TRANSFE
FieldValueIRS element (for citing)
Total501c3 Org19Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePROCEDURES FOR MONITORING USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATESFormAndLineReferenceDesc
ExplanationSCHEDULE F, PART I, LINE 2 AS OUTLINED IN KOMEN'S POLICIES AND PROCEDURES FOR RESEARCH AND TRAINING GRANTS, ALL GRANTEES ARE REQUIRED TO SUBMIT SCIENTIFIC PROGRESS REPORTS AND FINANCIAL REPORTS IN THE FORMAT REQUIRED BY KOMEN AND IN ACCORDANCE WITH THE SCHEDULE SET FORTH IN THE POLICIES AND ANY CHANGE REQUESTS THEY MAY HAVE FOR THEIR PROJECTS. ALL PROGRESS REPORTS AND REQUESTS ARE REVIEWED BY QUALIFIED STAFF. SEE SCHEDULE I, PART IV and SCHEDULE O, Part IX, Line 1 narrative FOR ADDITIONAL DETAILS.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (8 entries)

ActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsIndGross ReceiptsGrossReceiptsAmtRetained By ContractorRetainedByContractorAmtNet To OrganizationNetToOrganizationAmt
Event 360
Fundraising Consultantfalse$16,824,447$1,288,227$15,536,220
RKD GROUP LLC
Fundraising Consultantfalse$14,742,827$370,550$14,372,277
BOB CARTER COMPANIES
FUNDRAISING Consultantfalse$0$68,251$0
BLUE STATE DIGITAL INC
Marketing Consultantfalse$0$61,468$0
Revunami Inc
Marketing Consultantfalse$0$59,810$0
REDPEG MARKETING
Marketing Consultantfalse$995$50,463$0
THE DALTON AGENCY
Marketing Consultantfalse$0$9,450$0
TURNKEY PROMOTIONS INC
Marketing Consultantfalse$0$9,015$0
FieldValueIRS element (for citing)
Total Gross Receipts$31,568,269TotalGrossReceiptsAmt
Total Retained By Contractors$1,917,234TotalRetainedByContractorsAmt
Total Net To Organization$29,908,497TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesMTLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event13 Day 7Event1Nm
Gross Receipts Event1$15,197,300GrossReceiptsEvent1Amt
Charitable Contri Event1$14,917,986CharitableContriEvent1Amt
Gross Revenue Event1$279,314GrossRevenueEvent1Amt
Cash Prizes Event1$0CashPrizesEvent1Amt
Non Cash Prizes Event1$155,290NonCashPrizesEvent1Amt
Rent Facility Costs Event1$1,238,318RentFacilityCostsEvent1Amt
Food And Beverage Event1$1,352,226FoodAndBeverageEvent1Amt
Entertainment Event1$0EntertainmentEvent1Amt
Other Direct Expenses Event1$1,082,299OtherDirectExpensesEvent1Amt
Event2DC Walk 1Event2Nm
Gross Receipts Event2$858,115GrossReceiptsEvent2Amt
Charitable Contri Event2$760,401CharitableContriEvent2Amt
Gross Revenue Event2$97,714GrossRevenueEvent2Amt
Cash Prizes Event2$0CashPrizesEvent2Amt
Non Cash Prizes Event2$6,283NonCashPrizesEvent2Amt
Rent Facility Costs Event2$51,813RentFacilityCostsEvent2Amt
Food And Beverage Event2$14,741FoodAndBeverageEvent2Amt
Entertainment Event2$0EntertainmentEvent2Amt
Other Direct Expenses Event2$4,163OtherDirectExpensesEvent2Amt
Other Events Total1OtherEventsTotalCnt
Gross Receipts Other Events$125,649GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$125,649CharitableContriOtherEventsAmt
Cash Prizes Other Events$0CashPrizesOtherEventsAmt
Non Cash Prizes Other Events$3,200NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$0RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$1,500FoodAndBeverageOtherEventsAmt
Entertainment Other Events$0EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$451OthDirectExpnssOtherEventsAmt
Gross Receipts Total$16,181,064GrossReceiptsTotalAmt
Charitable Contributions Tot$15,804,036CharitableContributionsTotAmt
Gross Revenue Total Events$377,028GrossRevenueTotalEventsAmt
Cash Prizes Total Events$0CashPrizesTotalEventsAmt
Non Cash Prizes Total Events$164,773NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$1,290,131RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$1,368,467FoodAndBeverageTotalEventsAmt
Entertainment Total Events$0EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$1,086,913OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$3,910,284DirectExpenseSummaryEventsAmt
Net Income Summary-$3,533,256NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE G PART ITHE MAJORITY OF FUNDRAISING CONSULTING COSTS WITHOUT CORRESPONDING GROSS RECEIPTS ARE ASSOCIATED WITH KOMEN'S AFFILIATE NETWORK FUNDRAISING EFFORTS. THE GROSS RECEIPTS ARE RETAINED BY THE AFFILIATES.
NET INCOME SUMMARYSCHEDULE G PART II GROSS RECEIPTS ARE REDUCED BY THE AMOUNT OF CONTRIBUTIONS, PER IRS INSTRUCTIONS. THE CONTRIBUTIONS FOR FISCAL YEAR 2020 WERE $15,804,036.

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (110 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
African Women's Cancer Awareness Assoc
8955 Edmonston RoadGreenbeltMD20770731704355501c3$58,810Treatment
Albany Medical College
47 NEW SCOTLAND AVEALBANYNY12208141338310501c3$90,000Research
American Association for Cancer Research
615 ChestnutPHILADELPHIAPA19106236251649501c3$110,000Research
American Assoc on Health & Disability
110 N WASHINGTONROCKVILLEMD20850521884887501c3$20,000Education, Screening
Arlington Free Clinic
2921 11TH STREET SOUTHARLINGTONVA22204541671883501c3$59,999Treatment
Baylor College Medicine
ONE BAYLOR PLAZAHOUSTONTX770303411741613878501c3$868,347RESEARCH
Beth Israel Deaconess Medical Center
RES FIN OFFICEBOSTONMA02215042103881501c3$149,510Research
Boat People SOS
60066 LEESBURG PIKEFALLS CHURCHVA22041541563619501c3$14,018TREATMENT
Boston University
580 Harrison Ave 3-WBOSTONMA02118042103547501c3$127,000RESEARCH
Breast Care for Washington
4 ATLANTIC ST SWWASHINGTONDC20032455574713501c3$100,000Screening, treatment
Brigham & Women's Hospital
181 LONGWOOD AVE 5TH FLBOSTONMA02115042312909501c3$100,000Research
Burnham Institute for Medical Research
CANCER CTRLA JOLLACA92037510197108501c3$124,986RESEARCH
Cancer Care
275 SEVENTH AVENUENEW YORKNY10001131825919501c3$2,874,966EDUCATION, TREATMENT
CASA of Maryland Inc
8151 15TH AVEHYATTSVILLEMD20783521372972501c3$10,000TREATMENT
Children's Hospital Boston
PO BOX 414413BOSTONMA022414413042774441501c3$24,000RESEARCH
Columbia University Medical Center
722 W 168TH ST 4TH FLNEW YORKNY10032135598093501c3$373,899Research
Dana Farber Cancer Institute
44 BINNEY STBOSTONMA02115042263040501c3$2,305,848Research
Duke University Medical Center
PO Box 602651CharlotteNC282602651560532129501c3$225,952Research
Ethiopian Community Development Council
901 S HIGHLAND STARLINGTONVA22204521308986501c3$20,000TREATMENT
Facing Our Risk of Cancer Empowered
16057 TAMPA PALMS BLVDTAMPAFL33647650927702501c3$24,000EDUCATION
Fred Hutchinson Cancer Research Center
PO BOX 19024 MS J6-330SEATTLEWA90109563744111501c3$387,990Education, Research
H Lee Moffitt Cancer Center
12902 MAGNOLIA DRIVETAMPAFL33612593238636501c3$157,200Research
Harvard Medical School
HOLYOKE CENTER RM 600CAMBRIDGEMA02138042103580501c3$186,000RESEARCH
Indiana U (Indianapolis)
PO BOX 66057INDIANAPOLISIN462666057356001673501c3$1,429,984RESEARCH
Johns Hopkins University
1101 East 33rd StreetBALTIMOREMD21218520595110501c3$1,485,999Education, Research
Kingman Regional Medical Center
3269 STOCKTON HILL RDKINGMANAZ86409742388735501c3$21,927Education, Treatment
Korean Community Svc Ctr of Greater WA
7700 LITTLE RIVER TRNPKANNANDALEVA22003386005984501c3$10,212SCREENING, TREATMENT
Leland Stanford Jr University
PO BOX 44253SAN FRANCISCOCA941444253941156365501c3$209,074RESEARCH
Living Beyond Breast Cancer
354 WEST LANCASTER AVEHAVERFORDPA19041530196932501c3$6,000Education
Maricopa Health Foundation
2910 E CAMELBACK ROADPHOENIXAZ85016860777567501c3$7,500TREATMENT
Mary's Ctr for Maternal&Child Care Inc
2333 ONTARIO ROAD NWWASHINGTONDC20009521594116501c3$100,000Education, TREATMENT
Massachusetts General Hospital
PO BOX 414876BOSTONMA022414876042697983501c3$24,000Research
Massachusetts Institute of Technology
160 MEMORIAL DRIVECAMBRIDGEMA02139042103594501c3$242,269RESEARCH
Mayo Clinic Jacksonville
GRIFFIN Bldg RM 170JACKSONVILLEFL32224593337028501c3$280,388Research
Mayo Clinic Rochester
PO BOX 4008ROCHESTERMN559034008416011702501c3$120,000Research
Medical College of Wisconsin
Heidi Brittnacher Div of SurgicalMilwaukeeWI53226390806261501c3$90,000Research
Memorial Sloan-Kettering Cancer Ctr
633 3RD AVENUE 28TH FLNEW YORKNY10017131924236501c3$350,000RESEARCH
METAvivor Research and Support
1783 FOREST DRANNAPOLISMD21403371578088501c3$25,000EDUCATION
Mount Sinai School of Medicine
ONE GUSTAVE L LEVY PLNYNY10029136171197501c3$300,000RESEARCH
Mountain Park Health Cntr
3003 N 3RD ST STE 1600PHOENIXAZ85012860498020501c3$39,167EDUCATION, SCREENING, TREATMENT
Northwestern University - Chicago
633 CLARKEVANSTONIL60208362167817501c3$417,097Research
Nueva Vida Inc
2000 P STREET NWWASHINGTONDC20036541943145501c3$99,090Education, Treatment
Obesity Society
8757 GEORGIA AVENUESILVER SPRINGMD20910541438429501c3$16,000Research
Oregon Health & Science University
0690 SW BancroftPORTLANDOR97239752668014501c3$529,024Research
Partners for Cancer Care and Prevention
10 E LEE ST UNIT 1901BALTIMOREMD21202451605551501c3$7,500SCREENING
Princeton University
701 CARNEGIE CENTERPRINCETONNJ08540210634501501c3$176,000Research
Providence Portland Medical Center
PO Box 13993PORTLANDOR97213930386906501c3$150,000Research
Purdue University
23510 NETWORK PLCHICAGOIL606731235356002041501c3$120,000Research
Rockefeller University
1230 YORK AVE BOX 164NEW YORKNY10065131624158501c3$60,000Research
Stanford University
PO BOX 44253SAN FRANCISCOCA941444253941156365501c3$315,912Research
SUNY at Stony Brook
W5510 Melville LibSTONY BROOKNY11794146013200501c3$404,745Research
The Ohio State University College
700 Childrens DrCOLUMBUSOH43205316025986501c3$245,000Research
The Salk Institute
10010 N Torrey PNS RDLA JOLLACA92037376000511501c3$157,158Research
The University of Chicago
5801 S Ellis AveCHICAGOIL60637362177139501c3$228,704Research
The University of Toledo
2801 W Bancroft STTOLEDOOH436063390346401483501c3$149,645Research
The Wistar Institute
3601 SPRUCE STPHILADELPHIAPA191044265236434390501c3$240,000Research
Trustees of Columbia Univ
SPONSORED PROJECTS FINANCENEW YORKNY10027135598093501c3$30,000Research
Univ of North Carolina at Chapel Hill
104 AIRORT DRCHAPEL HILLNC275991350566001393501c3$926,194Research
Univ of Texas MD Anderson Cancer Center
PO Box 4390HOUSTONTX772104390746001118501c3$350,686Research
University of Alabama at Birmingham
1530 3RD AVE SBIRMINGHAMAL352940111636005396501c3$179,995Research
University of California-Davis
PO Box 989062W SACRAMENTOCA957989062956006143501c3$23,994Research
University of California-Los Angeles
10920 Wilshire BLVDLOS ANGELESCA90024956006143501c3$84,000Research
University of California-San Francisco
1600 Divisadero StSAN FRANCISCOCA94118946036493501c3$334,000Research
University of Kansas Center for Research
2385 IRVING HILL ROADLAWRENCEKS66045480680117501c3$150,000Research
University of Kansas Medical Center
3901 Rainbow BLVDKANSAS CITYKS66160481108830501c3$60,000Research
University of Kentucky Research Fndn
500 S LimestoneLEXINGTONKY405260001616033693501c3$59,899Research
University of Miami School of Medicine
1475 NW 12th AveMiamiFL33136590624458501c3$23,403RESEARCH
University of Michigan
Alexandra ThebaudAnn ArborMI481091274386006309501c3$340,000Research
University of Notre Dame du Lac
836a Grace HallNotre DameIN46556350868188501c3$150,000RESEARCH
University of Pennsylvania
3451 Walnut StPhiladelphiaPA191046205231352685501c3$1,028,640Research
University of Pittsburgh
123 University PlPittsburghPA152132303250966691501c3$94,141RESEARCH
University of South Carolina
1600 Hampton StColumbiaSC29208576001153501c3$81,000RESEARCH
University of Southern California
3500 S Figueroa StLos AngelesCA90089951642394501c3$148,688RESEARCH
University of Texas at Health Science Ctr
Elizabeth FrantzHoustonTX77030741587488501c3$81,000RESEARCH
University of Utah
201 S Pres CrSalt Lake CityUT84112876000525501c3$353,314RESEARCH
University of Virginia at School of Med
POBox 400195CharlottesvilleVA229044195237173411501c3$90,000RESEARCH
University of Washington
3917 Univ Way NESeattleWA98105916001537501c3$595,000RESEARCH
University of Wisconsin - Madison
21 North Park StMadisonWI537151218396006492501c3$66,415RESEARCH
UT HSC - San Antonio
7703 Floyd Curl DrSan AntonioTX77229741586031501c3$348,750RESEARCH
UT Southwestern Medical Center
UT Sw Grants MgmtDallasTX752841753746000203501c3$369,994RESEARCH
Utah Cancer Control Program
PO Box 144620Salt Lake CityUT841144620876000545501c3$114,959Education, Screening
UTMD Anderson Cancer Ctr
1515 Holcombe BlvdHoustonTX770304009746001118501c3$448,205RESEARCH
Vanderbilt University Medical Center
1161 21st Ave SAtlantaGA31192620476822501c3$773,586RESEARCH
Virginia Commonwealth University
800 E Leigh StRichmondVA23284546001758501c3$300,000RESEARCH
Wake Forest University Health Sciences
MEDICAL CNTR BLVDWinstonSalemNC27157223849199501c3$150,000RESEARCH
Washington University at St Louis
700 Rosedale AveSaint LouisMO63112430653611501c3$420,146RESEARCH
Wayne State University
5057 WOODWARD AVEDetroitMI48202366028429501c3$60,000RESEARCH
Weill Medical College of Cornell Univ
1300 York AvenueNew YorkNY10061131623978501c3$367,122RESEARCH
Wesley Community Center
1300 S 10th StreetPhoenixAZ85034860133770501c3$22,332Education, Treatment
Yale University
2 Whitney AvenueNew HavenCT06521060646973501c3$157,211RESEARCH
Coriell Institute for Medical Research
403 Haddon AvenueCamdenNJ081031505210672684501c3$33,919Research
ECOG Research and Education Foundation
1818 Market StreetPhiladelphiaPA19109391723095501c3$22,969Research
Emory University
1599 Clifton Rd NEAtlantaGA303224250580566256501c3$148,318Research
Georgetown U
PO BOX 571164WashingtonDC200571164530196603501c3$25,883Research
Georgetown University
37th O ST NWWashingtonDC200570004522339873501c3$60,000Research
Intermountain Healthcare Foundation Inc
36 S State STSalt Lake CityUT84111942854057501c3$18,750Education
Neighborhood Health
6677 RICHMOND HWYAlexandriaVA22305541849891501c3$48,313Education, Treatment
North Country Healthcare Inc
2920 N 4th StreetFlagstaffAZ860041816860663432501c3$24,167Education, Treatment
Ohio State Univ Research Foundation
1960 KENNY RD 4TH FLColumbusOH43210316025986501c3$40,000Research
Rush University Medical Center
1700 W Van Buren StChicagoIL60612362174823501c3$100,165Research
The Massachusetts General Hospital
PO Box 414876BostonMA022414876042697983501c3$129,749Research
The University of Texas at Austin
Communications Career ServicesAustinTX78712746000203501c3$150,000Research
Tufts University
800 Washington StreetBostonMA02111042985923501c3$60,000Research
University of Arizona
Bursar/Sponsored ProjectsTucsonAZ857334390742652689501c3$29,990Research
University of Chicago
5801 S Ellis AveChicagoIL60637382177139501c3$150,000Research
University of Cincinnati
51 Goodman DrCincinnatiOH452210222316000989501c3$30,000Research
University of Colorado Denver
13001 E 17th PlaceAuroraCO800452571846000555501c3$36,000Research
University of Pittsburgh
3100 CTHDRL of LearnPittsburghPA15260250965591501c3$579,109Research
Valleywise Health Foundation
2901 E Camelback RdPhoenixAZ85016860777567501c3$16,667Education
Recinto de Ciencias Medicas
PO BOX 365067SAN JUANPR009365067660433762501c3$18,797Treatment
FieldValueIRS element (for citing)
Total501c3 Org110Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePROCEDURES FOR MONITORING THE USE OF GRANTSFormAndLineReferenceDesc
ExplanationSCHEDULE I, PART I, LINE 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING GRANTS FROM THE TIME OF PRE-AWARD THROUGH CLOSEOUT ARE DESIGNED TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING A HIGH STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND AWARD PROCESS. KOMEN REQUIRES ALL GRANTEES TO SIGN A GRANT AGREEMENT SETTING FORTH THE TERMS OF THE GRANT, INCLUDING: PURPOSE, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AUDIT, AND EARLY TERMINATION RIGHTS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D. OR MASTERS-LEVEL RESEARCH GRANT MANAGER. FOR EDUCATION, SCREENING, AND TREATMENT GRANTS, PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED OR SUPERVISED THROUGHOUT THE GRANT TERM BY QUALIFIED PROFESSIONALS SERVING AS GRANTS MANAGERS. AS OUTLINED IN KOMEN'S POLICIES AND PROCEDURES FOR RESEARCH AND TRAINING GRANTS, GRANTEES ARE REQUIRED TO SUBMIT PROGRESS AND FINANCIAL REPORTS DETAILING PROGRESS TOWARD AIMS AND OBJECTIVES, MAJOR ACCOMPLISHMENTS, KEY DELIVERABLES AND CHALLENGES ENCOUNTERED, WITH A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES) AND WRITTEN JUSTIFICATION OF EXPENSES. AS APPROPRIATE, THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH GRANTEES TO GAIN A BETTER UNDERSTANDING OF THEIR WORK AND ADDRESS ANY CHALLENGES IMPACTING THE FUNDED PROGRAM. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. REQUESTS FOR CHANGES TO THE DESIGN OF THE FUNDED PROJECT OR BUDGET ARE SUBJECT TO PRIOR APPROVAL BY KOMEN IN ACCORDANCE WITH THE TERMS OF THE GRANT AGREEMENT. AS PART OF ITS OVERSIGHT PRACTICES, THE TERMS OF THE GRANT AGREEMENT MAY PROVIDE KOMEN WITH, AMONG OTHER THINGS, THE RIGHT TO REQUEST WITH REASONABLE PRIOR NOTICE TO THE GRANTEE: (1) ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE, (2) GRANTEE PARTICIPATION IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS, AND (3) WITH PRIOR WRITTEN NOTICE, ADJUSTMENT TO THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM. SEE SCHEDULE O, Part IX, Line 1 narrative FOR ADDITIONAL DETAILS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Subhendu Rath END 719
Sr. Dir, IT Enterprise Systems$130,017$0$0$0$39,175$0$7,414$0$2,988$0$179,594$0$0$0
Vanessa Hewitt
Sr. Dir., Internal Audit$166,701$0$0$0$1,873$0$10,468$0$8,511$0$187,553$0$0$0
Paula Schneider
President and CEO$576,289$0$50,000$0$5,124$0$14,949$0$8,217$0$654,579$0$0$0
Catherine Olivieri END 619
VP, HR and Corporate Secretary$233,509$0$0$0$3,828$0$14,723$0$13,162$0$265,222$0$0$0
Dana Brown
CHIEF OPERATING OFFICER$328,136$0$0$0$2,802$0$0$0$3,303$0$334,241$0$0$0
Ria Williams
Chief Financial Officer$227,125$0$0$0$2,333$0$11,616$0$14,302$0$255,376$0$0$0
Christina Alford
SVP, Development$294,114$0$30,000$0$2,101$0$16,724$0$2,814$0$345,753$0$0$0
Victoria Wolodzko
VP RESEARCH AND COM. HEALTH PR$233,936$0$24,000$0$2,316$0$11,546$0$2,636$0$274,434$0$0$0
Lori Maris
SVP, Affiliate Network$193,368$0$0$0$2,835$0$7,785$0$6,952$0$210,940$0$0$0
Eric Montgomery
VP, I.T. (END 4/19)$118,436$0$0$0$46,548$0$5,944$0$7,918$0$178,846$0$0$0
Linda Fisk
SVP, Marketing (END 10/19)$228,982$0$0$0$2,571$0$8,352$0$6,477$0$246,382$0$0$0
Sue Aldana
VP, Collaborative Revenue$166,169$0$0$0$3,132$0$9,296$0$3,241$0$181,838$0$0$0
Kimberly Sabelko
Sr. Dir., Scientific Strategy$164,099$0$0$0$2,688$0$10,439$0$10,667$0$187,893$0$0$0
Kimberly Johnson
Sr Dir Afri-Am Hlth Equity$165,528$0$0$0$3,100$0$0$0$2,110$0$170,738$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceFORM 990, SCHEDULE J, PART I, LINE 1AFormAndLineReferenceDesc
ExplanationSUPPLEMENTAL COMPENSATION INFORMATION SUSAN G. KOMEN'S TRAVEL POLICY DOES NOT REIMBURSE FOR FIRST CLASS OR BUSINESS CLASS TRAVEL. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND COUPONS MAY BE USED FOR NO COST UPGRADES. IN THE EVENT OF INTERNATIONAL TRAVEL WITH FLIGHT TIMES OF SIX HOURS OR MORE, AND PRE-APPROVAL, BUSINESS OR FIRST CLASS TRAVEL MAY BE PERMITTED IF THERE IS A MEDICAL ACCOMMODATION OR BUSINESS PURPOSE. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND FREE UPGRADES ARE USED TO MINIMIZE COSTS. FORM 990, SCHEDULE J, PART I, LINE 4A SEVERANCE PAYMENT Subhendu Rath RECEIVED A SEVERANCE PAYMENT OF $37,959. Eric Montgomery RECEIVED A SEVERANCE PAYMENT OF $45,409.ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp

Clothing And Household Goods ClothingAndHouseholdGoodsGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Noncash Contributions Rpt F990$128,311NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp
Securities Publicly TradedSecuritiesPubliclyTradedGrp
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp

Food Inventory FoodInventoryGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution5ContributionCnt
Noncash Contributions Rpt F990$3,856NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxIndDescDescContributionContributionCntNoncash Contributions Rpt F990NoncashContributionsRptF990AmtMethod Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)Airline Miles1$18,000FMV
Yes (X)Storage Facility1$1,500FMV
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE M, PART I, COLUMN (B)FormAndLineReferenceDesc
ExplanationTHE AMOUNTS IN THIS COLUMN REPRESENTS THE NUMBER OF ITEMS CONTRIBUTED OTHER THAN FOOD, WHICH IS NUMBER OF CONTRIBUTIONS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, QUESTION 6 - VOLUNTEERSVOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES.
FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTSSUSAN G. KOMEN IS A LEADING GLOBAL BREAST CANCER ORGANIZATION, HAVING FUNDED MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT OUTSIDE THE U.S. GOVERNMENT WHILE PROVIDING REAL TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $1 BILLION IN BREAST CANCER RESEARCH AND PROVIDED OVER $2.3 BILLION IN FUNDING FOR PATIENT NAVIGATION, SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 60 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. RESEARCH SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO MANY MAJOR ADVANCES IN BREAST CANCER SCIENCE. THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT, AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE FOCUSED ON BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER THROUGH BETTER APPROACHES FOR EARLY DETECTION AND DIAGNOSIS, UNDERSTANDING METASTASIS AND RECURRENCE, DEVELOPING NOVEL THERAPIES FOR ALL STAGES OF BREAST CANCER, AND DEVELOPING NEW APPROACHES TO ADDRESS DISPARITIES IN BREAST CANCER OUTCOMES, WITH THE GOAL OF SUPPORTING WORK THAT HAS SIGNIFICANT POTENTIAL TO LEAD TO NEW TREATMENTS, TECHNOLOGIES AND INTERVENTIONS. KOMEN'S RESEARCH PROGRAMS ARE GUIDED BY 59 OF THE WORLD'S LEADERS IN BREAST CANCER RESEARCH, ONCOLOGY AND ADVOCACY. THE SCIENTIFIC ADVISORY BOARD ASSISTS KOMEN IN SETTING ITS RESEARCH STRATEGY AND PRIORITIZING ITS RESEARCH INVESTMENT. THE KOMEN SCHOLARS LEAD AND PARTICIPATE IN KOMEN'S WORLD-CLASS SCIENTIFIC PEER REVIEW PROCESS. OUR ADVOCATES IN SCIENCE BRING THE COLLECTIVE PATIENT VOICE TO KOMEN'S RESEARCH PROGRAMS AND SCIENTIFIC ACTIVITIES, EMPHASIZING URGENCY AND PATIENT IMPACT. KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS, AND ORGANIZATIONS AROUND THE WORLD THROUGH A FAIR, TRANSPARENT, RIGOROUS, AND COMPETITIVE REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH INVESTMENT. IN FY20, KOMEN AWARDED 4 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, IN THE UNITED STATES. THESE GRANTS FOCUSED ON RESEARCH DESIGNED TO UNDERSTAND AND ADDRESS THE BIOLOGIC, BEHAVIORAL, SOCIAL AND SYSTEMIC CAUSES OF BREAST CANCER DISPARITIES. THE 4 DISPARITIES RESEARCH GRANTS AWARDED IN FY20 ARE: 1. Bryan Schneider, M.D., of Indiana University in Indianapolis, IN will study how genetic ancestry affects how African American women respond to breast cancer therapy, especially treatment induced side effects. He is especially interested in how mutations in a gene called SBF2 affect the development of taxane-induce peripheral neuropathy), a serious side effect linked to worse outcomes in African American patients. Dr. Schneider will also build a decision-making tool that will help African American patients work with their physicians to make the best treatment decisions. 2. Anne Rositch, Ph.D., of Johns Hopkins University in Baltimore, MD will address the disparity in breast cancer mortality in low resource settings by implementing and evaluating patient advocacy, navigation, and referral programs in Tanzania. This work will help patients overcome barriers to care that result in delays in treatment, late-stage diagnosis, or failure to complete treatment. By developing community-based programs to help patients stay in the continuum of care, this work can improve breast cancer outcomes in low-income areas across the globe. 3. Harikrishna Nakshatri, Ph.D., of Indiana University in Indianapolis, IN will study how genetic ancestry affects breast cancer biomarkers in women of African American and European ancestry. He will develop a tissue microarray platform to compare tiny samples of breast tumor, tissue around the tumors (tumor microenvironment), and normal breast tissue (using samples from the Komen Tissue Bank) from women of African, European and other ancestries. He will study how breast tissue biology differs between these populations and how genetic ancestry can impact breast cancer outcomes. These studies will shed light on the genetic factors affecting disparities in outcomes for AA breast cancer patients, and inform the development of better genetic biomarkers for early breast cancer detection for people of different genetic ancestry. 4. Mary-Claire King, Ph.D., of The University of Washington in Seattle, WA will use new genomic approaches to find the genetic basis for the higher rate of TNBC in African American women. Current sequencing technologies have been unable to identify mutations that might explain these higher rates of inherited TNBC. Dr. King will study the role of complex genetic mutations (such as deletion or insertion of large amounts of genetic material), that are not detectable by standard sequencing methods, in over 80 cases of inherited TNBC in African American women. These studies will address the gap in knowledge about genetics of TNBC in African American women, which will help inform treatment decisions and improve outcomes in AA women diagnosed with TNBC.
EDUCATION AND PATIENT SUPPORTKOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THEIR FIGHT AGAINST BREAST CANCER. OUR WEBSITE, KOMEN.ORG, PROVIDES CURRENT, SAFE, ACCURATE, COMPREHENSIVE, AND UNBIASED INFORMATION ABOUT BREAST CANCER, BASED ON SCIENTIFIC EVIDENCE. CONTENT IS OFFERED IN A VARIETY OF FORMATS INCLUDING INTERACTIVE VIDEO USING ANIMATION AND VOICEOVER IN ENGLISH AND SPANISH, ILLUSTRATIONS, CHARTS, GRAPHS, AND SHORT VIDEOS TO MEET THE LEARNING PREFERENCES AND NEEDS OF OUR WEB VISITORS. THE "ABOUT BREAST CANCER" SECTION OF KOMEN'S WEBSITE, CO-DEVELOPED WITH HARVARD MEDICAL SCHOOL FACULTY AND DANA-FARBERCANCER INSTITUTE STAFF, RECEIVED MORE THAN 5 MILLION PAGE VIEWS DURING FY20. KOMEN ALSO PROVIDES EVIDENCE-BASED, EASY-TO-READ EDUCATIONAL MATERIALS IN DOWNLOADABLE FORMATS ON KOMEN.ORG. EXAMPLES OF KOMEN EDUCATIONAL MATERIALS INCLUDE: A) BREAST SELF-AWARENESS MESSAGE CARDS IN MORE THAN 40 LANGUAGES, B) BREAST CANCER SPECIFIC BROCHURES AND FACTSHEETS, C) BOOKLETS WITH SUPPORT INFORMATION FOR SURVIVORS AND CO-SURVIVORS, AND D) TOOLKITS FOR BREAST CANCER OUTREACH AND EDUCATION FOR HISPANIC/LATINO IN ENGLISH AND SPANISH AND FOR BLACK AND AFRICAN-AMERICAN COMMUNITIES. THE SUSAN G. KOMEN "1-877 GO KOMEN" (1-877-465-6636) BREAST CARE HELPLINE OFFERS BREAST CANCER EDUCATION, PSYCHOSOCIAL SUPPORT, AND INFORMATION ABOUT COMMUNITY RESOURCES FOR PATIENTS, FAMILIES, AND THE GENERAL PUBLIC. THE CLINICAL TRIAL INFORMATION HELPLINE PROVIDES INFORMATION, RESOURCES, COACHING AND SUPPORT RELATED TO BREAST CANCER CLINICAL TRIALS. THE HELPLINE OPERATES FROM 9 A.M. - 10 P.M. E.T. THE SERVICE IS OFFERED IN ENGLISH, SPANISH, AND TAGALOG. DURING FY20, THE KOMEN HELPLINE RESPONDED TO MORE THAN 15,000 CALLS AND EMAILS. IN ADDITION, IN FY20 KOMEN DEVELOPED AND DELIVERED A CONFERENCE FOR WOMEN LIVING WITH METASTATIC BREAST CANCER IN THE WASHINGTON, D.C. REGION. THE CONFERENCE BRINGS PEOPLE WITH METASTATIC BREAST CANCER, CAREGIVERS, HEALTHCARE PROFESSIONALS, HEALTHCARE ORGANIZATIONS, SUPPORT ORGANIZATIONS AND OTHERS TOGETHER, WHO PARTICIPATE IN THE CARE OF PATIENTS WITH METASTATIC BREAST CANCER, TO DISCUSS SCIENTIFIC BREAKTHROUGHS, ONGOING CLINICAL TRIALS, QUALITY OF LIFE, AND INTEGRATIVE MEDICINE. THE CONFERENCE IS DESIGNED TO FILL THE NEEDS OF THE METASTATIC BREAST CANCER COMMUNITY AND SEEKS TO STRENGTHEN METASTATIC BREAST CANCER VOICES IN THE NATIONAL CAPITAL REGION BY CREATING OPPORTUNITIES FOR LEARNING, ENGAGEMENT AND ACTION. BREAST CANCER IS THE MOST COMMON CANCER IN WOMEN, WORLDWIDE, AND THE NUMBER OF CASES IS INCREASING IN NEARLY EVERY COUNTRY. THE NUMBER OF NEW BREAST CANCER CASES HAS MORE THAN DOUBLED AROUND THE WORLD IN THE LAST THREE DECADES, WITH HIGHEST INCREASES OBSERVED IN LOW- AND MIDDLE-INCOME COUNTRIES. THESE TRENDS ARE CONCERNING, WHICH IS WHY KOMEN WORKS TIRELESSLY TO PROVIDE SUPPORT TO BREAST HEALTH PROGRAMS WORLDWIDE. IT TAKES COLLABORATION AND STRONG PARTNERSHIPS TO MAKE A GLOBAL IMPACT. KOMEN STRIVES TO SERVE AS A "BRIDGE" - COLLABORATING WITH INTERNATIONAL NONPROFITS, CORPORATIONS, AND MINISTRIES OF HEALTH TO BRING TOGETHER PEOPLE AND ORGANIZATIONS TO DEVELOP PROGRAMS THAT ARE TAILORED TO THE SPECIFIC NEEDS OF THE COMMUNITY AND SENSITIVE TO CULTURAL DIFFERENCES. IN FY20, KOMEN'S GLOBAL PROGRAM CONTINUED ITS COLLABORATIVE WORK TO SUPPORT EDUCATION PROGRAMMING FOR PATIENTS AND FOR HEALTH PROFESSIONALS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN LATIN AMERICA AND AFRICA.
PUBLIC POLICY AND ADVOCACYSUSAN G. KOMEN IS THE NONPARTISAN VOICE OF MORE THAN 3.8 MILLION BREAST CANCER SURVIVORS, THOSE LIVING WITH THE DISEASE AND THE PEOPLE WHO LOVE THEM. KOMEN WORKS TO EDUCATE PEOPLE ABOUT PUBLIC POLICY ISSUES, SO THEY ARE EMPOWERED TO BECOME FORCEFUL ADVOCATES FOR THEMSELVES AND THEIR NEIGHBORS, AND THEN UNITES THEIR COLLECTIVE VOICES FOR MAXIMUM IMPACT. THROUGH OUR CENTER FOR PUBLIC POLICY, KOMEN ENSURES THAT OUR POLICYMAKERS ARE EDUCATED ABOUT THE NEEDS OF BREAST CANCER PATIENTS AND PRIORITIZE THE ISSUES IMPACTING THEM. ONLY THROUGH INFORMED GOVERNMENT ACTION CAN WE MAKE THE BROAD, SYSTEMIC AND LASTING CHANGE REQUIRED. EVERY TWO YEARS, THROUGH A TRANSPARENT, BROAD-BASED AND INTENSIVE VETTING AND SELECTION PROCESS, KOMEN WORKS TO IDENTIFY THE POLICY ISSUES WITH THE GREATEST POTENTIAL IMPACT. THIS PROCESS INCLUDES COLLECTING FEEDBACK FROM KOMEN AFFILIATES FROM ACROSS THE COUNTRY; ADVISORY GROUPS INCLUDING ADVOCATES IN SCIENCE (AIS) AND KOMEN SCHOLARS; REPRESENTATIVES FROM THE METASTATIC BREAST CANCER COMMUNITY AND KOMEN'S AFRICAN AMERICAN HEALTH EQUITY INITIATIVE; AND OTHER STAKEHOLDERS WITH A VESTED INTEREST IN BREAST CANCER-RELATED ISSUES. THE SELECTED ISSUES ARE THE BASIS FOR KOMEN'S STATE AND FEDERAL ADVOCACY EFFORTS. KOMEN'S 2019-2020 PUBLIC POLICY AND ADVOCACY PRIORITIES INCLUDED: EXPANDING ACCESS TO AFFORDABLE, HIGH-QUALITY HEALTH CARE FOR ALL PATIENT POPULATIONS; SUPPORTING INCREASED STATE AND FEDERAL FUNDING FOR BREAST CANCER RESEARCH; SUPPORTING STATE AND FEDERAL FUNDING FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S (CDC) NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM (NBCCEDP); ADVOCATING FOR STATE AND FEDERAL POLICIES TO IMPROVE INSURANCE COVERAGE OF BREAST CANCER TREATMENTS, INCLUDING THOSE THAT WOULD REQUIRE ORAL PARITY, PRECLUDE SPECIALTY TIERS AND PREVENT STEP THERAPY PROTOCOLS; ADVOCATING FOR STATE AND FEDERAL POLICIES TO REDUCE OR ELIMINATE OUT-OF-POCKET COSTS FOR MEDICALLY NECESSARY DIAGNOSTIC IMAGING; AND EVALUATING STATE AND FEDERAL POLICIES TO INCREASE PUBLIC ACCESS TO INFORMATION ABOUT AND PARTICIPATION IN CLINICAL TRIALS FOR ALL PATIENT POPULATIONS. IN ADDITION TO THE STATE AND FEDERAL WORK ON OUR PUBLIC POLICY AND ADVOCACY PRIORITIES, KOMEN ALSO ENGAGED ON ISSUES RELATED TO, COMPASSIONATE USE, CUSTOM BREAST PROTHESES, GENETIC TESTING, LYMPHEDEMA, MEDICARE WAITING PERIODS, PALLIATIVE CARE AND SURVIVORSHIP. KOMEN DEVELOPED AND IMPLEMENTED ADVOCACY CAMPAIGNS TO ENCOURAGE LAWMAKERS AND AGENCY OFFICIALS TO SUPPORT AND IMPLEMENT PROGRAMS THAT WOULD ADVANCE OUR PRIORITY ISSUES. KOMEN CONTINUED TO RECRUIT AND ENGAGE ADVOCATES TO FURTHER STRENGTHEN ITS GRASSROOTS ADVOCACY NETWORK. SCREENING AND PATIENT NAVIGATION GETTING REGULAR SCREENING TESTS, ALONG WITH EFFECTIVE AND QUALITY TREATMENT IF DIAGNOSED, LOWERS THE RISK OF DYING FROM BREAST CANCER. SCREENING TESTS CAN FIND BREAST CANCER EARLY, WHEN CHANCES FOR SURVIVAL ARE HIGHEST. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM. EVIDENCE SHOWS NAVIGATION IMPROVES ADHERENCE TO SCREENING RECOMMENDATIONS, AND THUS IMPROVES OVERALL OUTCOMES. KOMEN SUPPORTS FREE AND LOW-COST SCREENING PROGRAMS IN UNDERSERVED COMMUNITIES THAT HELP NAVIGATE PEOPLE TO QUALITY CARE, AND/OR PROVIDE COVERAGE FOR SCREENING SERVICES TO PEOPLE WITHOUT HEALTH INSURANCE, OR THOSE WITH HIGH CO-PAYS AND DEDUCTIBLES THAT MAKE SCREENING TOO COSTLY. KOMEN AWARDED ONE SCREENING COMMUNITY GRANT TO BREAST CARE FOR WASHINGTON, TO DEVELOP A MOBILE MAMMOGRAPHY PROJECT TO INCREASE ACCESS TO QUALITY SCREENING AND NAVIGATE WOMEN INTO DIAGNOSIS AND TREATMENT. TREATMENT AND PATIENT NAVIGATION BARRIERS TO QUALITY CARE ARE OFTEN ASSOCIATED WITH POOR BREAST CANCER OUTCOMES AND RESULTANT CANCER DISPARITIES AMONG SPECIFIC POPULATION GROUPS. ACCORDING TO QUALITATIVE DATA COLLECTED FROM ACROSS KOMEN'S AFFILIATE NETWORK, THE MOST COMMON BARRIERS TO QUALITY CARE IN THE UNITED STATES INCLUDE: (1) AVAILABILITY OF LOCAL SERVICES; (2) BREAST CANCER EDUCATION; (3) CULTURAL/LANGUAGE; (4) FEAR; (5) FINANCIAL; (6) INSURANCE; (7) TRANSPORTATION. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM TO ENSURE TIMELY DIAGNOSIS AND TREATMENT. EVIDENCE SHOWS PATIENT NAVIGATION IMPROVES ADHERENCE TO TREATMENT RECOMMENDATIONS, RESULTING IN IMPROVED OUTCOMES. KOMEN FUNDED THREE NONPROFIT ORGANIZATIONS IN SUPPORT OF PROGRAMS TO REDUCE STRUCTURAL, PERSONAL, SOCIOCULTURAL, AND FINANCIAL BARRIERS TO CARE, AND PROVIDE PATIENT NAVIGATION SERVICES FOR UNDERSERVED COMMUNITIES IN THE WASHINGTON, D.C. METRO AREA, SPECIFICALLY WARDS 2, 5, 7, AND 8, AND ALEXANDRIA CITY, VA. KOMEN'S TREATMENT ASSISTANCE PROGRAM, ADMINISTERED BY CANCERCARE, AIMS TO HELP WOMEN AND MEN IN BREAST CANCER TREATMENT WHO ARE FACING FINANCIAL CHALLENGES STAY IN TREATMENT BY PROVIDING LIMITED FINANCIAL ASSISTANCE, EDUCATION, AND SUPPORT SERVICES. FINANCIAL ASSISTANCE IS GRANTED TO UNDERSERVED, UNDERINSURED OR UNINSURED WOMEN AND MEN ACROSS THE COUNTRY UNDERGOING BREAST CANCER TREATMENT WHO MEET PRE-DETERMINED ELIGIBILITY CRITERIA. THIS PROGRAM PROVIDES FINANCIAL ASSISTANCE FOR TREATMENT-RELATED COSTS, INCLUDING TRANSPORTATION TO AND FROM TREATMENT, CHILD/ELDER CARE, HOME CARE, ORAL PAIN/ANTI-NAUSEA MEDICATIONS, ORAL CHEMOTHERAPY/HORMONE THERAPY, LYMPHEDEMA CARE/SUPPLIES, PALLIATIVE CARE, AND DURABLE MEDICAL EQUIPMENT. WE SERVED MORE THAN 4400 PEOPLE THROUGH THIS PROGRAM IN FY20.
EXECUTIVE COMMITTEEFORM 990, PART VI, LINE 1A THE ORGANIZATION'S BYLAWS PROVIDE FOR AN EXECUTIVE COMMITTEE COMPRISED OF A MINIMUM OF FIVE MEMBERS INCLUDING THE BOARD CHAIR, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND ADDITIONAL BOARD MEMBERS, AS RECOMMENDED BY THE GOVERNANCE COMMITTEE AND APPOINTED BY THE BOARD OF DIRECTORS. MEMBERS OF THE EXECUTIVE COMMITTEE MUST EITHER BE DIRECTORS OF THE ORGANIZATION OR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE BYLAWS PROVIDE THE EXECUTIVE COMMITTEE WITH THE AUTHORITY TO: (A) APPOINT MEMBERS TO NON-STANDING COMMITTEES OF THE ORGANIZATION, AND NAME CHAIRS OF SUCH COMMITTEES; (B) AUTHORIZE UNBUDGETED DISBURSEMENTS BY THE ORGANIZATION IN ACCORDANCE WITH THE SPECIFIC EXPENDITURE AUTHORITY PRESCRIBED BY THE BOARD OF DIRECTORS; (C) EMPLOY AGENTS; AND (D) CARRY INTO EXECUTION SUCH OTHER MEASURES AS IT DETERMINES WILL PROMOTE THE PURPOSE OF THE ORGANIZATION. THE COMMITTEE ALSO MAY EXERCISE, WHEN THE BOARD IS NOT IN SESSION, ALL OF THE AUTHORITY OF THE BOARD IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE ORGANIZATION WITH CERTAIN EXCEPTIONS SUCH AS REPEALING ANY BOARD RESOLUTIONS, AMENDING THE ORGANIZATION'S ARTICLES OR BYLAWS, OR MERGING OR DISSOLVING THE ORGANIZATION. THIS DELEGATION DOES NOT RELIEVE THE BOARD OF ANY OF ITS RESPONSIBILITIES IMPOSED BY LAW, AND THE COMMITTEE ENDEAVORS TO LIMIT ITS EXERCISE OF AUTHORITY TO TIME SENSITIVE ISSUES. ON MARCH 24, 2020, THE BOARD OF DIRECTORS UNANIMOUSLY ADOPTED THE SIXTH AMENDED AND RESTATED BYLAWS, WHICH, AMONG OTHER THINGS, EXPANDED THE MAXIMUM NUMBER OF DIRECTORS FROM 15 TO 19 AND REQUIRED THE ANNUAL MEETING OF THE BOARD OF DIRECTORS TO TAKE PLACE WITHIN 90 DAYS BEFORE THE EXPIRATION OF THE FISCAL YEAR. CHANGES TO ORGANIZATION BYLAWS FORM 990, PART VI, LINE 4 ON MARCH 24, 2020, THE BOARD OF DIRECTORS UNANIMOUSLY ADOPTED THE SIXTH AMENDED AND RESTATED BYLAWS, WHICH, AMONG OTHER THINGS, EXPANDED THE MAXIMUM NUMBER OF DIRECTORS FROM 15 TO 19 AND REQUIRED THE ANNUAL MEETING OF THE BOARD OF DIRECTORS TO TAKE PLACE WITHIN 90 DAYS BEFORE THE EXPIRATION OF THE FISCAL YEAR.
DESCRIBE THE PROCESS USED BY MGMT AND/OR GOV BODY TO REVIEW 990FORM 990, PART VI, QUESTION 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVEL MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR SUBSEQUENT PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWS, MAKES RECOMMENDATIONS, AND APPROVES THE FORM 990 FOR PRESENTATION TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING.
DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFL OF INTERFORM 990, PART VI, QUESTION 12C KOMEN'S CONFLICT OF INTEREST POLICY REQUIRES EVERY BOARD MEMBER, OFFICER, COMMITTEE MEMBER, ADVISORY BOARD MEMBER, AND EMPLOYEE TO AVOID CONFLICTS OF INTEREST. IT ALSO REQUIRES THESE PERSONS TO REPORT ANY ACTUAL AND/OR POTENTIAL CONFLICTS OF INTEREST AS SOON AS POSSIBLE. REPORTS ARE REVIEWED BY THE GENERAL COUNSEL'S OFFICE AND/OR INTERNAL AUDIT, AND APPROPRIATE ACTION IS TAKEN PURSUANT TO THE CONFLICT OF INTEREST POLICY. FURTHER, KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL BOARD MEMBERS, OFFICERS, COMMITTEE MEMBERS, ADVISORY BOARD MEMBERS, AND EMPLOYEES TO REVIEW THE CONFLICT OF INTEREST POLICY AND DISCLOSE ANY ADDITIONAL ACTUAL/POTENTIAL CONFLICTS OF INTEREST. THESE ANNUAL DISCLOSURES ARE REVIEWED IN THE SAME MANNER. THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS RECEIVES, AND REVIEWS ALL REPORTED ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AND THE RELATED ACTION TO ADDRESS THEM.
OFFICES & POSIT. FOR WHICH PROCESS WAS USED, & YEAR PROCESS BEGUNFORM 990, PART VI, QUESTION 15A & 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND BEST PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER KEY EMPLOYEES; GRANTING THE CHIEF EXECUTIVE OFFICER WITH THE AUTHORITY TO DETERMINE COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND ANY INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010 AND IS REVIEWED ANNUALLY. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. BENCHMARKING WAS CONDUCTED FOR THE CHIEF EXECUTIVE OFFICER AND ALL EXECUTIVE TEAM MEMBERS' COMPENSATION TO EXTERNAL MARKET DATA IN 2019, TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION.
AVAIL OF GOV DOCS, CONFLICT OF INTEREST, &FIN STMTS TO GEN PUBLICFORM 990, PART VI, QUESTION 19 KOMEN'S FINANCIAL STATEMENTS AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 AND THE CONFLICT OF INTEREST POLICY ARE NOT PUBLISHED ONLINE BUT ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
ADDITIONAL DETAIL ON GRANTSFORM 990, PART IX, LINE 1 For more than 35 years, Susan G. Komen has been working toward its vision of creating a world without breast cancer through its mission of ensuring all people get access to the care they need and investing in breakthrough research to better detect, prevent and treat breast cancers at every stage, and ultimately, to discover the cures. As a result of the economic and healthcare system impacts from the COVID-19 pandemic, in May 2020 Komen began a series of changes to strengthen its financial and operational position to continue to deliver on its vision and mission. Komen began a process to centralize all operations, consolidating its independent Affiliates into its headquarters organization, resulting in a single organization. This consolidation will enable Komen to leverage the combined expertise of its mission leaders to deliver a united mission program, utilizing technology as a key driver to connect to people who need to access care where they are and to help improve the patient experience; resulting in administrative and operational efficiencies. Komen implemented additional cost reduction measures including reducing headquarters staff by 24% in the first quarter and our Affiliates who will consolidate in FY21 experienced a 67% staff reduction. Our consolidated headcount is anticipated to be reduced by at least 33% less than prior fiscal year, pre-pandemic. In addition, salaries were reduced by 5% - 15% with higher level positions taking the larger percentage reductions. Komen also suspended its 403B match program for the remaining months in 2020. These changes will be reflected in the 990 filed for our FY21 Fiscal Year. Central to Komens vision is a steadfast commitment to investing in breakthrough research. In response to the COVID-19 pandemics impact on the health care system, including suspension of non-pandemic related medical research at most research universities across the country, Komen did not award new grants in FY2020. To be clear, our commitment to saving lives by investing in breakthrough research and meeting the most critical needs in communities is unchanged and unwavering. Despite the economic uncertainty and challenging fundraising environment, Komen maintained its commitment to all awarded projects. We currently have an incredible portfolio of nearly 200 research grants, about half which are focused on recurrence and metastasis. In fact, since 1982 our total investment in metastatic breast cancer research has reached more than $210 million, supporting over 500 research grants and 50 clinical trials almost 100 of these Komen-funded research projects are still active. In addition, 43 of our ongoing research projects involve clinical trials, speeding discovery to patient benefit. Another priority for our research is to better understand and develop solutions for the disparities in breast cancer outcomes, particular for people of color. In fact, 24 of our current research projects are focused on this, including $1 million in new grants we awarded this fiscal year. ADDITIONAL DETAIL ON EVENT PROD. EXPENSES INCLUDED ON OTHER EXPENSE FORM 990, PART IX, LINE 24 KOMEN PAYS 50% OF THE COST OF ALL T-SHIRTS FOR THE 111 SUSAN G. KOMEN RACE FOR THE CURE AND MORE THAN PINK WALK EVENTS CONDUCTED BY THE KOMEN AFFILIATES DURING THE FISCAL YEAR. RACE FOR THE CURE AND MORE THAN PINK WALK EVENTS CONDUCTED BY THE KOMEN AFFILIATES DURING THE FISCAL YEAR.
OTHER CHANGES IN NET ASSETS OR FUND BALANCESFORM 990, PART XI, LINE 9 RESCINDED GRANTS $798,867 ------------ TOTAL $798,867 ============